abstract |
The present disclosure provides an adeno-associated virus (AAV) virion with a denatured capsid protein, wherein the AAV virion, when administered via intravitreal injection, exhibits more infectious retinal cells compared to wild-type AAV. The present disclosure further provides methods of delivering gene products to retinal cells in an individual and methods of treating eye diseases. |